Newsletter

CIHN -  Leading Biotech pick on Breakout alert  . 

CIHN - High Alert Poised Breakout Stem Cell Gem

We hope our team took advantage of yesterday's CIHN healthy pullback after it's two day rally to accumulate for what it setup to be a strong chance of a breakout today.
Our winning stem cell gem has been trading very healthy and bullish, breaking out on high volume days and accumulating on low volume days, just how a healthy stock should.
CIHN has been very predictable and has been trading just as we been expecting, making this an easy play for our team to always come out winning.
CIHN has been trading so well that it has been covered multiple times by many groups and after yesterday's accumulation, looks like many groups have picked this gem up again and are calling CIHN their big pick for today.
This heavy coverage only means a strong chance of high volume and on high volume as we seen CIHN always moves up strong.
All indicators point up so we hope your ready for another big move today.

What to Know About This Gem Today
- CIHN Rafael Gonzalez, company’s advisory board will be a guest speaker at the 22nd Annual World Congress on Anti-Ageing, Regenerative & Aesthetic Medicine, in Orlando FL.
- CIHN currently has 8 qualified patients with 3 ready to go to DR in the next two weeks.
- CIHN opening new treatment locations in Guadalajra, Mexico, and Cabo St. Lucas. CIHN is also in negations to install a proprietary lab in Santa Domingo, Dominican Republic. 

- CIHN appoints Dr. Leonel Liriano as their Regenerative BioScience Medical Director. 

- CIHN has begun processing applicants for treatments via its website at no cost complimentary consultations regarding the applicant’s suitability to qualify for company’s revolutionary stem cell procedures.

- CIHN announces plans to enter into strategic alliance to store stem cells for future use.

- CIHN announces Site of 2nd International Treatment Facility; Facility is Approved for Stem Cell Therapies by Mexico's Equivalent of US FDA.  See what Dr. Gonzalez has to say about this idea, "We are now in collaborative talks with a new California based stem cell banking company with years of research in the stem cell field called TheBioBox. They will store adult stem cells (bone marrow and fat) for Regenerative Biosciences patients for future use. I am particularly excited about arranging a "marriage" between RBS and this new company as it will allow us to offer "cutting edge services" to our patients. This is important because stem cells age just as we do and the younger you are when you harvest and store them, the greater the possibilities. Researchers have found that by replacing aging cells with younger ones, we may be able to stop or slow down the progression of age related diseases."
Again we see CIHN making big moves and plans to make the company grow and have a fruitful future.
View CIHN’s full article: Caribbean International Holdings (CIHN), Announces Site of 2nd International Treatment Facility; Facility is Approved for Stem Cell Therapies by Mexico's Equivalent of US FDA

Our Morning Trading Tip
- CIHN accumulated strongly today and chart indicates a breakout under way very soon.
- Today's CIHN's healthy pullback on light volume is a bullish indicator after yesterday's high volume breakout.
- This is one thing to looks for in a healthy trading stock, heavy volume on the breakouts and low volume on the pullbacks.
CIHN's accumulated and ready chart

Dr. Leonel Liriano Working On Professional Athletes
CIHN Medical Director Dr. Leonel Liriano did New York Yankees CY Young pitcher Bartolo Colon which means they are likely to do many more big name athletes which is blockbuster news" Here is more proof "Doctor: 10 pitchers want to undergo Bartolo Colon's procedure"

View full article:
 (Doc: After Yankees’ Bartolo Colon, 10 More Pitchers Want Stem Cell Procedure)

Mets sign 40-years-old Bartolo Colon for two years, 20 million:
Looks like Dr. Leonel Liriano’s stem cell therapy worked on pitcher Bartolo Colon, after three years of his treatment, the young pitcher got singed last year for a two year 20 million dollars contract with the Mets

View full article:

(Bartolo Colon and Mets agree to a 2-year deal)

About CIHN
- CIHN (Caribbean International Holdings, Inc.) focuses in the area of regenerative and personalised medicine.
- CIHN provides adult stem cell incubation and storage to individuals looking for the potential to protect and ensure their future quality of life.
- CIHN is headquartered at Sarasota, FL.

- CIHN's website: (http://www.regenerativebioscience.com)

Leading Stock Alerts

 GENERAL NOTICE AND DISCLAIMER (Please read carefully): We are engaged in the business of advertising and marketing companies for monetary compensation. By viewing or using Leadingstockalerts.com (hereafter referred to as "AMS") you hereby fully agree to our Legal Disclaimer & Disclosure ( http://www.Leadingstockalerts.com/disclaimer ) and our Privacy Policy. This is not a solicitation to buy or sell a security. This is for entertainment purposes only. Never invest into a stock discussed on our website or the AMS newsletter unless you can afford to lose your entire investment. AMS is wholly owned by Advanced Marketing Services LLC. AMS is not a registered broker dealer or a registered investment advisor. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. Please consult with a certified financial advisor before making any investment decisions. This is sponsored advertising and does not purport to provide an analysis of the featured company’s financial position, operations or prospects and is not to be construed as a recommendation or solicitation by AMS, to buy or sell any security in any jurisdiction. The information contained herein is based on sources that AMS  believes to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. AMS encourages readers and investors to supplement the information in this report with independent research and other professional advice. All information on the featured company is provided by the company profiled, or is available from public sources and AMS makes no representations or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this report are statements of judgment as of the date of publication and are subject to change without further notice and may not necessarily be reprinted in future publications or elsewhere. None of the materials or advertisements herein constitute offers or solicitations to  purchase or sell securities of the company profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead AMS strongly urges you to conduct a complete and independent investigation of the respective companies. AMS does not offer such advice or analysis and AMS further urges you to consult your own independent tax, business, financial and investment advisors. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the company profiled. AMS, its operators, owners, employees, and affiliates may have interests or positions in equity securities of the companies profiled by AMS, some or all of which may have been acquired prior to the dissemination of this report and may increase or decrease these positions at any time. This report may contain  forward-looking-statements, which involve risks and uncertainties. Accordingly no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward statement. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking-statements made by AMS about the company profiled. If applicable investors are also directed to consider other risks and uncertainties discussed in documents filed by the profiled company with the Securities and Exchange Commission. AMS undertakes no obligation to publicly release the result of any revisions to these forward-looking-statements which may be made to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events. 
Notice of Stock Price Volatility and Movements: Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.
 Third Party Advertising Agency/Advertiser: AMS expects to be compensated ten thousand dollars for investor communications services from a third party non affiliate for coverage on Caribbean International Holdings Inc, (CIHN). (hereafter referred to as "PICK"). AMS receives this compensation as a production budget for advertising efforts and will retain amounts over and above the cost of production, copy-writing services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding PICK. When compensation for a production budget for its marketing and advertising efforts are retained, AMS will disclose any future compensation if such compensation occurs. In future, AMS will disclose any and all further and future compensation. Some of the services performed have or may  include profiling the company on the AMS website and issuing opinions concerning this new profile in newsletters. Anyone viewing the AMS website or its newsletters should assume the hiring party or affiliates of the hiring party own shares of PICK, which they plan to liquidate. Further, it must be understood that the liquidation of those shares may or may not negatively impact the share price. AMS, the third party advertiser, has represented that it is not a current shareholder of PICK and that it does not buy or sell any shares in PICK during the period that this advertisement is being disseminated.

You're receiving this newsletter because you signed up at Leadingstockalerts.com
If you are no longer interest in receiving this email, you may unsubscribe.

 Copyright © Leading Stock Alerts 2012-2013.                               
Leading Stock Alerts - 16192 Coastal Hwy Lewes DE 19958 

Stocks covered:	Compensation:	Avg $ Volume for Period:
CIHN	$10000	UNKNOWN
Max Profit: 60.71 %	Gain at close: 0.00 %
*We think that this promoter is a part of a group of promoters.

Newsletter

CIHN - leading biotech pick on breakout alert May 14, 2014 08:05